Loading...

PE Streptavidin PE Streptavidin

Pricing & Availability
Regulatory Status
RUO
Other Names
Streptavidin-Phycoerythrin, SAv-PE
Ave. Rating
Submit a Review
Product Citations
publications
SAV_PE_082808.jpg
C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
  • SAV_PE_082808.jpg
    C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
See PE spectral data
Cat # Size Price Quantity Check Availability Save
405204 500 µg SEK1638
Check Availability


Need larger quantities of this item?
Request Bulk Quote
405203 100 µg SEK471
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Streptavidin binds to biotin with high affinity. Streptavidin-Phycoerythrin (PE) is useful for detecting biotinylated antibodies. The excitation of PE by 488 nm laser light induces a light emission maximum of 575 nm.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat, All Species
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
Streptavidin is conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml (concentration relates to the Streptavidin only component of the conjugate)
Storage & Handling
The streptavidin-PE solution should be stored undiluted between 2°C and 8°C, and protected from exposure to light. Do not freeze.
Application

FC - Quality tested

ICFC - Verified
Recommended Usage

This streptavidin product is quality control tested by immunofluorescent staining with flow cytometric analysis. The concentration provided is based upon molecular mass of streptavidin independent of any additional molecular mass that might be added by the PE conjugation. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Streptavidin-Phycoerythrin (PE) is useful as a second step reagent for indirect immunofluorescent staining, when used in conjunction with biotinylated primary antibodies. The average molecular weight of Streptavidin-PE is 360 kD and Streptavidin alone is 52 kD.

Application References
  1. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245.
  2. Nishimoto KP,et al. 2008. J. Immunol. 181:4010.PubMed
  3. Niki T, et al. 2009. J. Biol. Chem. 284:32344. PubMed
  4. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  5. Scatizzi JC, et al. 2012. J. Immunol. 188:3307. PubMed
  6. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  7. Shibata T, et al. 2012. Int Immunol. 24:613. PubMed
  8. Baccala R, et al. 2012. J. Immunol. 189:5976. PubMed
  9. Grevers LC, et al. 2013. Ann Reheum Dis. 72:278. PubMed
  10. Woo SJ, et al. 2013. J Leukoc Biol. 93:363. PubMed
  11. Ashbaugh JJ, et al. 2013. J. Immunol. 190:4525. PubMed
  12. Reading JL, 2013. J. immunol. 190:4542. Pubmed.
  13. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  14. Gunaydin G, et al. 2014. Vaccine. 32:470. PubMed
  15. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  16. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  17. He X, et al. 2014. J Immunol. 193:1314. PubMed
  18. Wang W, et al. 2014. PNAS. 111:14466. PubMed
  19. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  20. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  21. Kim Yu, et al. 2015. PLoS One. 10:120294. PubMed
  22. Hua X, et al. 2015. PloS One. 10:128039. PubMed
Product Citations
  1. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  2. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  3. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  4. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  5. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  6. Campisi L, et al. 2022. Nature. 606:945. PubMed
  7. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  8. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  9. Cao Y, et al. 2023. Nature. 614:521. PubMed
  10. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  11. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  12. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  13. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  14. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  15. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  16. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  17. Feng J, et al. 2022. Immunity. 55:405. PubMed
  18. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  19. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  20. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  21. Ke F, et al. 2023. Elife. 12:. PubMed
  22. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  23. Silva RP, et al. 2023. Elife. 12:. PubMed
  24. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  25. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  26. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  27. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  28. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  29. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  30. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  31. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  32. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  33. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  34. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  35. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  36. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  37. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  38. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  39. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  40. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  41. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  42. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  43. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  44. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  45. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  46. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  47. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  48. Biswas S, et al. 2021. Nature. 591:464. PubMed
  49. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  50. Gniffke EP, et al. 2020. medRxiv. . PubMed
  51. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  52. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  53. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  54. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  55. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  56. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  57. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  58. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  59. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  60. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  61. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  62. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  63. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  64. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  65. Cao Y, et al. 2022. Nature. :. PubMed
  66. Im S, et al. 2016. Nature. 537:417-421. PubMed
  67. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  68. Schanda N, et al. 2021. Cells. 10:. PubMed
  69. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  70. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  71. Köchl R, et al. 2020. Elife. 9:00. PubMed
  72. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  73. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  74. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  75. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  76. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  77. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  78. Cao Y, et al. 2022. Nature. 602:657. PubMed
  79. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  80. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  81. Weiß S, et al. 2020. medRxiv. . PubMed
  82. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  83. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  84. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  85. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  86. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  87. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  88. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  89. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  90. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  91. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  92. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  93. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  94. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  95. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  96. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  97. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  98. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  99. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  100. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  101. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  102. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  103. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  104. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  105. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  106. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  107. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  108. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  109. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  110. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  111. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  112. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  113. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  114. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  115. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  116. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  117. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  118. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  119. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  120. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  121. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  122. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  123. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  124. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  125. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  126. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  127. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  128. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  129. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  130. Dan JM, et al. 2021. Science. :371. PubMed
  131. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  132. He X, et al. 2014. J Immunol. 193:1314. PubMed
  133. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  134. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  135. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  136. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  137. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  138. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  139. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  140. Wells DK, et al. 2020. Cell. 183:818. PubMed
  141. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  142. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  143. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  144. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  145. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  146. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  147. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  148. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  149. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  150. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  151. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  152. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  153. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  154. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  155. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  156. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  157. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  158. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  159. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  160. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  161. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  162. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  163. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  164. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  165. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  166. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  167. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  168. Campisi L, et al. 2022. Nature. 606:945. PubMed
  169. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  170. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  171. Cao Y, et al. 2023. Nature. 614:521. PubMed
  172. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  173. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  174. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  175. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  176. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  177. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  178. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  179. Feng J, et al. 2022. Immunity. 55:405. PubMed
  180. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  181. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  182. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  183. Ke F, et al. 2023. Elife. 12:. PubMed
  184. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  185. Silva RP, et al. 2023. Elife. 12:. PubMed
  186. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  187. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  188. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  189. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  190. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  191. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  192. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  193. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  194. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  195. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  196. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  197. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  198. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  199. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  200. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  201. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  202. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  203. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  204. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  205. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  206. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  207. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  208. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  209. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  210. Biswas S, et al. 2021. Nature. 591:464. PubMed
  211. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  212. Gniffke EP, et al. 2020. medRxiv. . PubMed
  213. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  214. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  215. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  216. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  217. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  218. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  219. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  220. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  221. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  222. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  223. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  224. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  225. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  226. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  227. Cao Y, et al. 2022. Nature. :. PubMed
  228. Im S, et al. 2016. Nature. 537:417-421. PubMed
  229. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  230. Schanda N, et al. 2021. Cells. 10:. PubMed
  231. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  232. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  233. Köchl R, et al. 2020. Elife. 9:00. PubMed
  234. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  235. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  236. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  237. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  238. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  239. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  240. Cao Y, et al. 2022. Nature. 602:657. PubMed
  241. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  242. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  243. Weiß S, et al. 2020. medRxiv. . PubMed
  244. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  245. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  246. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  247. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  248. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  249. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  250. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  251. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  252. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  253. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  254. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  255. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  256. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  257. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  258. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  259. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  260. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  261. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  262. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  263. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  264. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  265. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  266. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  267. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  268. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  269. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  270. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  271. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  272. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  273. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  274. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  275. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  276. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  277. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  278. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  279. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  280. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  281. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  282. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  283. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  284. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  285. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  286. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  287. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  288. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  289. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  290. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  291. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  292. Dan JM, et al. 2021. Science. :371. PubMed
  293. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  294. He X, et al. 2014. J Immunol. 193:1314. PubMed
  295. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  296. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  297. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  298. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  299. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  300. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  301. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  302. Wells DK, et al. 2020. Cell. 183:818. PubMed
  303. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  304. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  305. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  306. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  307. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  308. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  309. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  310. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  311. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  312. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  313. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  314. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  315. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  316. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  317. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  318. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  319. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  320. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  321. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  322. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  323. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  324. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 6    Revision Date: 06-17-2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Pricing & Availability
Regulatory Status
RUO
Other Names
Streptavidin-Phycoerythrin, SAv-PE
Ave. Rating
Submit a Review
Product Citations
publications
SAV_PE_082808.jpg
C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
  • SAV_PE_082808.jpg
    C57BL/6 splenocytes stained with 145-2C11 biotin, followed by SAV-PE
See PE spectral data
Cat # Size Price Quantity Check Availability Save
405204 500 µg SEK1638
Check Availability


Need larger quantities of this item?
Request Bulk Quote
405203 100 µg SEK471
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Streptavidin binds to biotin with high affinity. Streptavidin-Phycoerythrin (PE) is useful for detecting biotinylated antibodies. The excitation of PE by 488 nm laser light induces a light emission maximum of 575 nm.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat, All Species
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
Streptavidin is conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml (concentration relates to the Streptavidin only component of the conjugate)
Storage & Handling
The streptavidin-PE solution should be stored undiluted between 2°C and 8°C, and protected from exposure to light. Do not freeze.
Application

FC - Quality tested

ICFC - Verified
Recommended Usage

This streptavidin product is quality control tested by immunofluorescent staining with flow cytometric analysis. The concentration provided is based upon molecular mass of streptavidin independent of any additional molecular mass that might be added by the PE conjugation. For flow cytometric staining, the suggested use of this reagent is ≤0.06 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Streptavidin-Phycoerythrin (PE) is useful as a second step reagent for indirect immunofluorescent staining, when used in conjunction with biotinylated primary antibodies. The average molecular weight of Streptavidin-PE is 360 kD and Streptavidin alone is 52 kD.

Application References
  1. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245.
  2. Nishimoto KP,et al. 2008. J. Immunol. 181:4010.PubMed
  3. Niki T, et al. 2009. J. Biol. Chem. 284:32344. PubMed
  4. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  5. Scatizzi JC, et al. 2012. J. Immunol. 188:3307. PubMed
  6. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  7. Shibata T, et al. 2012. Int Immunol. 24:613. PubMed
  8. Baccala R, et al. 2012. J. Immunol. 189:5976. PubMed
  9. Grevers LC, et al. 2013. Ann Reheum Dis. 72:278. PubMed
  10. Woo SJ, et al. 2013. J Leukoc Biol. 93:363. PubMed
  11. Ashbaugh JJ, et al. 2013. J. Immunol. 190:4525. PubMed
  12. Reading JL, 2013. J. immunol. 190:4542. Pubmed.
  13. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  14. Gunaydin G, et al. 2014. Vaccine. 32:470. PubMed
  15. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  16. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  17. He X, et al. 2014. J Immunol. 193:1314. PubMed
  18. Wang W, et al. 2014. PNAS. 111:14466. PubMed
  19. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  20. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  21. Kim Yu, et al. 2015. PLoS One. 10:120294. PubMed
  22. Hua X, et al. 2015. PloS One. 10:128039. PubMed
Product Citations
  1. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  2. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  3. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  4. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  5. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  6. Campisi L, et al. 2022. Nature. 606:945. PubMed
  7. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  8. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  9. Cao Y, et al. 2023. Nature. 614:521. PubMed
  10. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  11. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  12. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  13. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  14. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  15. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  16. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  17. Feng J, et al. 2022. Immunity. 55:405. PubMed
  18. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  19. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  20. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  21. Ke F, et al. 2023. Elife. 12:. PubMed
  22. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  23. Silva RP, et al. 2023. Elife. 12:. PubMed
  24. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  25. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  26. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  27. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  28. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  29. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  30. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  31. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  32. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  33. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  34. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  35. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  36. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  37. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  38. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  39. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  40. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  41. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  42. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  43. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  44. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  45. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  46. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  47. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  48. Biswas S, et al. 2021. Nature. 591:464. PubMed
  49. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  50. Gniffke EP, et al. 2020. medRxiv. . PubMed
  51. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  52. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  53. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  54. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  55. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  56. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  57. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  58. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  59. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  60. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  61. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  62. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  63. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  64. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  65. Cao Y, et al. 2022. Nature. :. PubMed
  66. Im S, et al. 2016. Nature. 537:417-421. PubMed
  67. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  68. Schanda N, et al. 2021. Cells. 10:. PubMed
  69. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  70. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  71. Köchl R, et al. 2020. Elife. 9:00. PubMed
  72. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  73. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  74. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  75. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  76. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  77. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  78. Cao Y, et al. 2022. Nature. 602:657. PubMed
  79. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  80. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  81. Weiß S, et al. 2020. medRxiv. . PubMed
  82. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  83. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  84. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  85. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  86. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  87. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  88. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  89. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  90. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  91. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  92. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  93. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  94. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  95. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  96. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  97. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  98. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  99. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  100. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  101. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  102. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  103. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  104. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  105. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  106. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  107. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  108. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  109. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  110. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  111. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  112. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  113. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  114. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  115. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  116. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  117. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  118. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  119. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  120. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  121. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  122. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  123. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  124. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  125. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  126. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  127. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  128. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  129. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  130. Dan JM, et al. 2021. Science. :371. PubMed
  131. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  132. He X, et al. 2014. J Immunol. 193:1314. PubMed
  133. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  134. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  135. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  136. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  137. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  138. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  139. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  140. Wells DK, et al. 2020. Cell. 183:818. PubMed
  141. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  142. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  143. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  144. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  145. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  146. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  147. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  148. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  149. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  150. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  151. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  152. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  153. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  154. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  155. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  156. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  157. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  158. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  159. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  160. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  161. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  162. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed
  163. Martínez-Blanco Á, et al. 2021. Front Immunol. 12:713697. PubMed
  164. Wang H, et al. 2020. Mol Oncol. 14:991. PubMed
  165. Zhang Y, et al. 2017. Journal of Immunological Methods. 10.1016/j.taap.2017.05.020. PubMed
  166. Wu Y, et al. 2021. Immunity. 54:2595. PubMed
  167. Goel RR, et al. 2022. Cell. 185:1875. PubMed
  168. Campisi L, et al. 2022. Nature. 606:945. PubMed
  169. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  170. Wu Y, et al. 2022. Sci Adv. 8:eabm7833. PubMed
  171. Cao Y, et al. 2023. Nature. 614:521. PubMed
  172. Weskamm LM, et al. 2022. STAR Protoc. 3:101902. PubMed
  173. Mekkaoui L, et al. 2023. Mol Ther Methods Clin Dev. 28:116. PubMed
  174. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  175. Hernandez SPA, et al. 2023. Front Immunol. 13:1035344. PubMed
  176. Pušnik J, et al. 2023. Nat Commun. 14:572. PubMed
  177. Knyphausen P, et al. 2023. Nat Commun. 14:768. PubMed
  178. Yeh CH, et al. 2022. Immunity. 55:272. PubMed
  179. Feng J, et al. 2022. Immunity. 55:405. PubMed
  180. Tas JMJ, et al. 2022. Immunity. 55:1856. PubMed
  181. Melzi E, et al. 2022. Immunity. 55:2168. PubMed
  182. Vyasamneni R, et al. 2023. Cell Rep Methods. 3:100388. PubMed
  183. Ke F, et al. 2023. Elife. 12:. PubMed
  184. Li D, et al. 2023. Int J Oncol. 62:. PubMed
  185. Silva RP, et al. 2023. Elife. 12:. PubMed
  186. Nozuma S, et al. 2023. JCI Insight. 8:. PubMed
  187. García-Vega M, et al. 2023. iScience. 26:106562. PubMed
  188. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  189. Fathi M, et al. 2023. iScience. 26:106482. PubMed
  190. Xiao C, et al. 2023. Nat Aging. 3:418. PubMed
  191. Lv X, et al. 2023. Acta Pharm Sin B. 13:1631. PubMed
  192. Li X, et al. 2023. Nat Commun. 14:2929. PubMed
  193. Tundidor I, et al. 2023. Nat Commun. 14:3130. PubMed
  194. Chen K, et al. 2023. Gut Pathog. 15:28. PubMed
  195. Golubovskaya V, et al. 2023. Cancers (Basel). 15:. PubMed
  196. Eger C, et al. 2016. PLoS One. 11: 0150479. PubMed
  197. Yang J, et al. 2016. Sci Rep. 6:38238. PubMed
  198. Chen T, et al. 2016. J Exp Med. 13(13):3025-3039. PubMed
  199. Tian L, et al. 2021. Int J Mol Sci. 22: . PubMed
  200. Lv X, et al. 2022. Acta Pharm Sin B. 12:735. PubMed
  201. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  202. Larsen SB, et al. 2021. Cell Stem Cell. 28:1758. PubMed
  203. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  204. Viborg N, et al. 2019. Oncoimmunology. 8:e1663107. PubMed
  205. Yamakawa N, et al. 2012. Int Immunol. 25:45. PubMed
  206. Grevers L, et al. 2013. Ann Rheum Dis. 72:278. PubMed
  207. Gatineau J, et al. 2022. Front Immunol. 13:982839. PubMed
  208. Trendel N, et al. 2021. Sci Signal. 14:eaay9363. PubMed
  209. Datta S, et al. 2014. J Leukoc Biol. 95:853. PubMed
  210. Biswas S, et al. 2021. Nature. 591:464. PubMed
  211. Wellner A, et al. 2021. Nat Chem Biol. 17:1057. PubMed
  212. Gniffke EP, et al. 2020. medRxiv. . PubMed
  213. Ruiz–Camp J, et al. 2019. EMBO Mol Med. 11:3. PubMed
  214. Nie X, et al. 2017. Cellular & Molecular Immunology. 10.1038/cmi.2017.17. PubMed
  215. Hernandez-Franco JF, et al. 2022. Front Immunol. 13:990900. PubMed
  216. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  217. Xiao C, et al. 2022. iScience. 25:103934. PubMed
  218. Imbrechts M, et al. 2022. iScience. 25:104705. PubMed
  219. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  220. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  221. Ashbaugh J, et al. 2013. J Immunol. 190:4525. PubMed
  222. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  223. Hu Y, et al. 2022. Nat Commun. 13:5313. PubMed
  224. Kim Y, et al. 2015. PLoS One. 10:120294. PubMed
  225. He X, et al. 2021. Emerg Microbes Infect. 10:1555. PubMed
  226. Nishimoto K, et al. 2008. J Immunol. 181:4010. PubMed
  227. Cao Y, et al. 2022. Nature. :. PubMed
  228. Im S, et al. 2016. Nature. 537:417-421. PubMed
  229. Weiß S, et al. 2020. J Infect Dis. 222:1629. PubMed
  230. Schanda N, et al. 2021. Cells. 10:. PubMed
  231. Tsukamoto H, et al. 2013. Biochem Biophys Res Commun. 440:31. PubMed
  232. Phiwpan K, et al. 2015. PLoS One. 10:128198. PubMed
  233. Köchl R, et al. 2020. Elife. 9:00. PubMed
  234. Niki T, et al. 2009. J Biol Chem. 284:32344. PubMed
  235. Ping Y, et al. 2020. Front Cell Dev Biol. 0.890972222. PubMed
  236. Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
  237. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  238. Kristensen NP, et al. 2022. J Clin Invest. 132:. PubMed
  239. Qiu C, et al. 2022. Front Immunol. 12:764949. PubMed
  240. Cao Y, et al. 2022. Nature. 602:657. PubMed
  241. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  242. Lucas A, et al. 2015. PLoS One. 10:117160. PubMed
  243. Weiß S, et al. 2020. medRxiv. . PubMed
  244. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  245. Kim C, et al. 2019. Cell Rep. 29:2202. PubMed
  246. Hansen UK, et al. 2020. Front Immunol. 11:373. PubMed
  247. Reading J, et al. 2013. J Immunol. 190:4542. PubMed
  248. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  249. Mei H, et al. 2021. J Hematol Oncol. 14:161. PubMed
  250. Repáraz D, et al. 2022. J Immunother Cancer. 10:. PubMed
  251. Tschismarov R, et al. 2021. JCI Insight. 6:. PubMed
  252. Richardson LS, et al. 2020. Lab Chip. 3.948611111. PubMed
  253. Hebbar N, et al. 2022. Nat Commun. 13:587. PubMed
  254. Kacherovsky N, et al. 2019. Nat Biomed Eng. 0.66875. PubMed
  255. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  256. McWilliam H, et al. 2016. Nat Immunol. 17: 531-537. PubMed
  257. Zhang S, et al. 2016. Sci Transl Med. 8: 341ra77. PubMed
  258. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  259. Woo S, et al. 2013. J Leukoc Biol. 93:363. PubMed
  260. Baccala R, et al. 2012. J Immunol. 189:5976. PubMed
  261. Delacher M, et al. 2020. Immunity. 52:295. PubMed
  262. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  263. Parente-Pereira AC, et al. 2022. STAR Protoc. 3:101319. PubMed
  264. Baltierra-Uribe SL, et al. 2021. Eur J Immunol. 51:2641. PubMed
  265. Schoutrop E, et al. 2022. Oncoimmunology. 11:2093426. PubMed
  266. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  267. Roewe J, et al. 2020. Nat Commun. 3.260416667. PubMed
  268. Carestia A, et al. 2019. Cell Rep. 28:896. PubMed
  269. Scatizzi J, et al. 2012. J Immunol. 188:3307. PubMed
  270. Tian B, et al. 2017. Front Immunol. 10.3389/fimmu.2017.00956. PubMed
  271. Schoofs T et al. 2019. Immunity. 50(6):1513-1529 . PubMed
  272. Guo C, et al. 2021. Cell Rep Med. 2:100448. PubMed
  273. Chen YL, et al. 2021. J Biol Chem. :101420. PubMed
  274. Zhong MC, et al. 2021. J Exp Med. 218:. PubMed
  275. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  276. Günaydın G, et al. 2014. Vaccine. 32:470. PubMed
  277. Matt P, et al. 2015. PLoS One. 10: 0137474. PubMed
  278. Davis Z, et al. 2016. PLoS Pathog. 12: 1005421. PubMed
  279. Gniffke EP, et al. 2020. J Infect Dis. 222:1965. PubMed
  280. Leung EYL, et al. 2020. Mol Ther Oncolytics. 16:289. PubMed
  281. Nowak W, et al. 2020. EBioMedicine. 50:290-305.. PubMed
  282. Matsuda T, et al. 2022. iScience. 25:105324. PubMed
  283. Kim SP, et al. 2022. Cancer Immunol Res. :OF1. PubMed
  284. Cheloha RW, et al. 2021. RSC chem biol. 2:1692. PubMed
  285. Okamoto Y, et al. 2021. J Cell Sci. 134:. PubMed
  286. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  287. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  288. Lu X, et al. 2019. Cell Rep. 28:472. PubMed
  289. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  290. Wang W, et al. 2014. Proc Natl Acad Sci U S A. 111:14466. PubMed
  291. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  292. Dan JM, et al. 2021. Science. :371. PubMed
  293. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  294. He X, et al. 2014. J Immunol. 193:1314. PubMed
  295. Kanno A, et al. 2013. Int Immunol. 25:413. PubMed
  296. Walker MR, et al. 2022. Sci Adv. 8:eabj9513. PubMed
  297. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  298. Deng J, et al. 2021. J Leukoc Biol. 110:1171. PubMed
  299. Murakami Y, et al. 2014. J Immunol. 193:5208. PubMed
  300. Mchedlidze T, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.20. PubMed
  301. Kurashima Y, et al. 2021. Nat Commun. 12:1067. PubMed
  302. Wells DK, et al. 2020. Cell. 183:818. PubMed
  303. Schürch CM, et al. 2020. Cell. 182:1341. PubMed
  304. Chappaz S, et al. 2010. J Immunol. 185:3514. PubMed
  305. Altman JB, et al. 2018. Health Sci Rep. 1:e74. PubMed
  306. Hirunwidchayarat W, et al. 2017. Biochem Biophys Res Commun. 10.1016/j.bbrc.2017.07.012. PubMed
  307. Wang EY, et al. 2022. Cell Rep Methods. 2:. PubMed
  308. DanDan Huang, Lang Bao 2016. J Microbiol Immunol Infect. 49:859-865. PubMed
  309. Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed
  310. Pedersen NW, et al. 2019. Nat Commun. 10:837. PubMed
  311. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  312. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  313. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  314. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  315. Lyngaa R, et al. 2014. Clin Cancer Res. 20:1768. PubMed
  316. Tripathi S, et al. 2016. Proc Natl Acad Sci U S A. 113: 1555 - 1564. PubMed
  317. Ando Y, Oku T, Tsuji T 2016. PLoS One. 11: 0162208. PubMed
  318. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
  319. Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed
  320. Lautz JD, et al. 2019. Sci Rep. 9:10890. PubMed
  321. Kenney M, et al. 2017. Journal of Immunological Methods. 10.1016/j.jim.2017.07.001. PubMed
  322. Holm JS, et al. 2022. Nat Commun. 13:1935. PubMed
  323. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  324. Shibui A, et al. 2011. Exp Parasitol. 129:318. PubMed

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 6    Revision Date: 06-17-2019

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account